Clinical manifestations and pathophysiology of heparin-induced thrombocytopenia;Thrombopenies induites par les heparines: Manifestations cliniques et physiopathologie

Presse Medicale

Volumn 27, Issue SUPPL. 2, 1998, Pages 7-12

  Gruel, Y ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HEPARIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; THROMBOCYTE FACTOR 4; THROMBOPLASTIN; ANTICOAGULANT AGENT;

ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTERY THROMBOSIS; CLINICAL FEATURE; CONFERENCE PAPER; DRUG INDUCED DISEASE; ENDOTHELIUM CELL; HUMAN; LUNG EMBOLISM; PATHOPHYSIOLOGY; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; VEIN THROMBOSIS; BLOOD; CHEMICALLY INDUCED DISORDER; REVIEW;

ANTICOAGULANTS; HEPARIN; HUMANS; IMMUNOGLOBULIN G; PLATELET ACTIVATION; THROMBOCYTOPENIA;

EID: 3543044943     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Warkentin T, Kelton J. Interaction of Heparin with platelets, including Heparin-induced thrombocytopenia. In: Low -molecular-weight heparins in prophylaxis and therapy of thromboembolic diseases. Bounameaux H ed. Marcel Dekker, New York 1994 ; 75-127.
2. Chong B. Heparin-induced thrombocytopenia. Br J Hoematol 1995 ; 89:431-9.
3. Eichinger S, Kyrle P, Brenner B et al. Thrombocytopenia associated with low-molecular weight heparin. Lancet 1991 ; 337:1425-6.
4. Elalamy I, Potevin F, Lecrubier C, Bara L, Marie J, Samama M. A fatal low-molecular-weight heparin-associated thrombocytopenia after hip surgery: possible usefulness of PF4-heparin ELISA test. Blood Coagul Fibrinol 1996; 7:665-71.
5. Laster J, Silver D. Heparin-coated catheters and heparin-induced thrombocytopenia. J Vasc Surg 1988 ; 7:667-72.
6. Schmitt B, Adelman B. Heparin-associated thrombocytopenia : a critical review and pooled analysis. Am J Med Sci 1993 ; 305:208-15.
7. Warkentin TE. Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet micoparticle generation, and altered procoagulant/ anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Transfusion Med 1996 ; X:249-58.
8. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996 ; 101:502-7.
9. Warkentin T, Hirte H, Anderson D, Wilson W, O'Connell G, Lo R. Transient global amnesia associated with acute heparin-induced thrombocytopenia. Am J Med 1994; 97:489-91.
10. Towne J, Bernhard V, Hussey C, Garancis J. White clot syndrome. Peripheral vascular complications of heparin therapy. Arch Surg 1979 ; 114:372-7.
11. Warkentin TE. Heparin-induced skin lesions. Br J Haematal 1996 ; 92:494-7.
12. Gruel Y, Leroy J, Guérois C et al. Thrombopénie et thrombose sous héparine. Nécessité des tests d'agrégation avant le traitement par l'héparine de bas poids moléculaire. Presse Med 1985 ; 14:166.
13. Ernest D, Fisher M. Heparin-induced thrombocytopaenia complicated by bilateral adrenal haemorrhage. Intens Care Med 1991 ; 17:238-40.
14. Chong B, Castaldi P. Platelet proaggregating effect of heparin: possible mechanism for non-immune heparin associated thrombocytopenia. Aust NZ J Med 1986 ; 16:715-16.
15. Rhodes G, Dixon R, Silver D. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg Gynecol Obstet 1973 ; 136:409-16.
16. Cines D, Kaywin P, Bina M, Tomaski A, Schreiber A. Heparin-associated thrombocytopenia. N Engl J Med 1980 , 303:788-95.
17. Gruel Y, Lang M, Darnige L et al. Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosis. Lancet 1990 ; 336:1077-8.
18. Chong B, Grace C, Rozenbefg M. Heparin-induced thrombocytopenia : effect of heparin platelet antibody on platelets. Br J Haematol 1981 : 49:531-40.
19. Chong B, Pitney W, Castaldi P. Heparin-induced thrombocytopenia : association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet 1982 ; ii:1246-9.
20. Andersen G. Insights into hepanrin-induced thrombocytopenia. Br J Haematol 1992 ; 80:504-8.
21. Kelton J, Sheridan D, Santos A et al. Heparin-induced thrombocytopenia : laboratory studies. Blood 1988 ; 72:925-30.
22. Amiral J, Wolf M, Fischer AM, Boyer-Neumann C, Vissac AM, Meyer D. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol 1996 ; 92:954-9.
23. Green D, Harris K, Reynolds N, Roberts N, Patterson R. Heparin immune thrombocytopenia-evidence for a heparin-platelet complex as the antigenic determinant. J Lab Clin Med 1978 ; 91:167-75.
24. Gruel Y, Boizard-Boval B, Wautier J. Further evidence that alpha-granule components such as platelet factor 4 are involved in platelet-IgG-heparin interactions during heparin-associated thrombocytopenia. Thromb Haemost 1993 ; 70:374-5.
25. Makhoul R, Devine D, Brenckman WJ, McCann R, Greenberg C. Evidence for the involvement of platelet glycoproteins other than GP Ib in heparin-associated thrombocytopenia and thrombosis. Thromb Res 1987 ; 45:421-5.
26. Amiral J, Bridey F, Dreyfus M et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992 ; 68:95-6.
27. Zucker M, Katz I. Platelet factor 4 : production, structure, and physiologic and immunologic action. Prac Soc Exp Biol 1992; 198:693-702.
28. Greinacher A, Alban S, Dummel V, Franz G, Mueller-Eckhardt C. Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia. Thromb Haemost 1995 ; 74:886-92.
29. Pouplard C, Amiral J, Borg J, Vissac A, Delahousse B, Gruel Y. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparaid sodium (Orgaran). Br J Haematol 1997 ; 99:273-80.
30. Amiral J, Marfaing-Koka A, Wolf M et al. Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 1996 ; 88:410-16.
31. Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia : isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 1994 ; 71:247-51.
32. Warkentin T, Hayward C, Boshkov L et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity : an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994 ; 84:3691-9.
33. Boshkov LK, Warkentin TE, Hayward CPM, Andrew M, Kelton JG. Heparin-induced Thrombocytopenia and Thrombosis - Clinical and Laboratory Studies. Br J Haematol 1993; 84:322-8.
34. Visentin G, Ford S, Scott J, Aster R. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994 ; 93:81-8.
35. Cines D, Tomaski A, Tannenbaum S. Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med 1987 ; 316:581-9.
36. Leroy J, Leclerc M, Delahousse B et al. Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216). Semin Thromb Hemost 1985 ; 11:326-9.
37. Pouplard C, May M, Delahousse B et al. Development of antibodies specific to PF4/Heparin complexes in patients undergoing cardio-pulmonary bypass. Thromb Haemost 1997 ; supplement : 448.
38. Burgess J, Lindeman R, Chesterman C, Chong B. Single ammo acid mutation of Fcg receptor is associated with the development of heparin-induced thrombocytopenia. Br J Haematol 1995 ; 91:761-66.
39. Brandt J, Isenhart C, Osbome J, Ahmed A, Anderson C. On the role of platelet FcgRlla phenotype in heparin-induced thrombocytopenia. Thromb Haemost 1995 ; 74:1564-72.
40. Arepally C, McKenzie SE, Jiang XM, Ponacz M, Cines DB. Fc gamma RIIA H/R(131) polymorphism, subclass-specific IgC anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis. Blood 1997 ; 89:370-5.
41. Warkentin T, Levine M, Hirsh J et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995 ; 352:1330-5.